COVID-19大流行期间急性心肌梗死的病例率、治疗方式与结局
从2020年2月23日起,AMI住院率每周下降19.0例,持续5周,随后每周增加10.5例。早期COVID-19期间AMI的O/E死亡比值升高至1.27,STEMI患者尤为显著(1.96),后期STEMI的O/E比值进一步升至2.40。
要点
- COVID-19早期AMI住院率每周下降19.0例,后期每周回升10.5例。
- 早期COVID-19期间AMI的O/E死亡比值升至1.27,STEMI患者达1.96。
- 后期STEMI的O/E死亡比值进一步升至2.40,风险调整后OR为1.52。
核心结论
- COVID-19早期和后期AMI住院率发生显著变化,且结局更差,STEMI患者死亡风险增加尤为突出。
主要发现
- 从2020年2月23日起,AMI住院病例每周减少19.0例(95%CI -29.0至-9.0),持续5周;此后每周增加10.5例(95%CI +4.6至+16.5)。
- 各时期患者人口学特征、心血管合并症和治疗方式无显著差异。
- 早期COVID-19期间AMI的O/E死亡比值为1.27(95%CI 1.07-1.48),STEMI患者为1.96(95%CI 1.22-2.70)。
- 后期COVID-19期间AMI的O/E死亡比值无统计学差异(1.23,95%CI 0.98-1.47),但STEMI患者为2.40(95%CI 1.65-3.16),风险调整后OR为1.52(95%CI 1.02-2.26)。
临床怎么用
- 疫情期间需关注AMI住院率下降及STEMI患者死亡风险升高,优化急救流程与资源配置。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The coronavirus disease 2019 (COVID-19) pandemic has changed health care delivery worldwide. Although decreases in hospitalization for acute myocardial infarction (AMI) have been reported during the pandemic, the implication for in-hospital outcomes is not well understood. OBJECTIVE: To define changes in AMI case rates, patient demographics, cardiovascular comorbidities, treatment approaches, and in-hospital outcomes during the pandemic. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study retrospectively analyzed AMI hospitalizations that occurred between December 30, 2018, and May 16, 2020, in 1 of the 49 hospitals in the Providence St Joseph Health system located in 6 states (Alaska, Washington, Montana, Oregon, California, and Texas). The cohort included patients aged 18 years or older who had a principal discharge diagnosis of AMI (ST-segment elevation myocardial infarction [STEMI] or non-ST-segment elevation myocardial infarction [NSTEMI]). Segmented regression analysis was performed to assess changes in weekly case volumes. Cases were grouped into 1 of 3 periods: before COVID-19 (December 30, 2018, to February 22, 2020), early COVID-19 (February 23, 2020, to March 28, 2020), and later COVID-19 (March 29, 2020, to May 16, 2020). In-hospital mortality was risk-adjusted using an observed to expected (O/E) ratio and covariate-adjusted multivariable model. EXPOSURE: Date of hospitalization. MAIN OUTCOMES AND MEASURES: The primary outcome was the weekly rate of AMI (STEMI or NSTEMI) hospitalizations. The secondary outcomes were patient characteristics, treatment approaches, and in-hospital outcomes of this patient population. RESULTS: The cohort included 15 244 AMI hospitalizations (of which 4955 were for STEMI [33%] and 10 289 for NSTEMI [67%]) involving 14 724 patients (mean [SD] age of 68 [13] years and 10 019 men [66%]). Beginning February 23, 2020, AMI-associated hospitalizations decreased at a rate of -19.0 (95% CI, -29.0 to -9.0) cases per week for 5 weeks (early COVID-19 period). Thereafter, AMI-associated hospitalizations increased at a rate of +10.5 (95% CI, +4.6 to +16.5) cases per week (later COVID-19 period). No appreciable differences in patient demographics, cardiovascular comorbidities, and treatment approaches were observed across periods. The O/E mortality ratio for AMI increased during the early period (1.27; 95% CI, 1.07-1.48), which was disproportionately associated with patients with STEMI (1.96; 95% CI, 1.22-2.70). Although the O/E mortality ratio for AMI was not statistically different during the later period (1.23; 95% CI, 0.98-1.47), increases in the O/E mortality ratio were noted for patients with STEMI (2.40; 95% CI, 1.65-3.16) and after risk adjustment (odds ratio, 1.52; 95% CI, 1.02-2.26). CONCLUSIONS AND RELEVANCE: This cross-sectional study found important changes in AMI hospitalization rates and worse outcomes during the early and later COVID-19 periods. Future studies are needed to identify contributors to the increased mortality rate among patients with STEMI.
引用
- Gluckman TJ, Wilson MA, Chiu ST, et al. Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic. JAMA Cardiol. 2020. PMID: 32766756. doi:10.1001/jamacardio.2020.3629
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。